ConductScience.org, home

Paper9596703

Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.

Norris KA. Infect Immun, 1998. Cited by 53 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Papers, record 9596703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9596703

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.
PubMed
Journal
Infect Immun
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2020-07-24
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Norris KAK A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement ActivationMajor topic
Complement Inactivator ProteinsMajor topic
Membrane GlycoproteinsMajor topic
Protozoan ProteinsMajor topic
Trypanosoma cruziMajor topic
Animals
Cell Differentiation
Complement C3b
DNA, Complementary
Drug Resistance
Gene Expression
Genetic Vectors
Humans
Polymerase Chain Reaction
Protein Binding
Recombinant Proteins
Transfection

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI032719NIAID NIH HHSUnited StatesR01AI032719PubMed and NIHNIH RePORTER
AI32719NIAID NIH HHSUnited StatesR01AI032719PubMed and NIHNIH RePORTER
R29AI032719NIHNIH RePORTER

Download CSV of grants

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
146840Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.Infect Immun1975https://conductscience.org/library/papers/46840PubMed
29009282Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.Infect Immun1997https://conductscience.org/library/papers/9009282PubMed
3815433Protective effects of specific antibodies in Trypanosoma cruzi infections.J Immunol1976https://conductscience.org/library/papers/815433PubMed
46992059The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes.Parasitology1980https://conductscience.org/library/papers/6992059PubMed
56801127Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.J Immunol1982https://conductscience.org/library/papers/6801127PubMed
66207242Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi.J Immunol1984https://conductscience.org/library/papers/6207242PubMed
73042767Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases.J Biol Chem1988https://conductscience.org/library/papers/3042767PubMed
82973433gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.Immunology1988https://conductscience.org/library/papers/2973433PubMed
92663722Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.Infect Immun1989https://conductscience.org/library/papers/2663722PubMed
102504665The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.Immunol Lett1989https://conductscience.org/library/papers/2504665PubMed
111717552Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.J Immunol1991https://conductscience.org/library/papers/1717552PubMed
121324472A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania.Nucleic Acids Res1992https://conductscience.org/library/papers/1324472PubMed
137688032FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues.J Exp Med1993https://conductscience.org/library/papers/7688032PubMed
148262633Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi.Infect Immun1994https://conductscience.org/library/papers/8262633PubMed
158063427Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease.Infect Immun1994https://conductscience.org/library/papers/8063427PubMed
168905613Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.Microb Pathog1996https://conductscience.org/library/papers/8905613PubMed
17807672Studies on the selective lysis and purification of Trypanosoma cruzi.J Exp Med1975https://conductscience.org/library/papers/807672PubMed

Download CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42429568Glycocalyx-Driven Immunomodulation in Trypanosoma cruzi: Structures, Host Responses, Diagnostic and Therapeutic Targeting.Parasite Immunol2026https://conductscience.org/library/papers/42429568PubMed
41810676Transcriptomic dynamics reveals sequential acquisition of complement resistance during prolonged starvation of Trypanosoma cruzi epimastigoteMem Inst Oswaldo Cruz2026https://conductscience.org/library/papers/41810676PubMed
41568009Towards a map of the immune system manipulation network by Trypanosoma cruzi.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41568009PubMed
41187580The grand escape - how pathogens outsmart the human complement system.Immunobiology2025https://conductscience.org/library/papers/41187580PubMed
38239357Microbial evasion of the complement system: a continuous and evolving story.Front Immunol2023https://conductscience.org/library/papers/38239357PubMed
36590580An induced population of Trypanosoma cruzi epimastigotes more resistant to complement lysis promotes a phenotype with greater differentiation, invasiveness, and release of extracellular vesicles.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36590580PubMed
35401838Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.Theranostics2022https://conductscience.org/library/papers/35401838PubMed
34975884Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?Front Immunol2021https://conductscience.org/library/papers/34975884PubMed
34778110Impact of the Extracellular Vesicles Derived From Trypanosoma cruzi: A Paradox in Host Response and Lipid Metabolism Modulation.Front Cell Infect Microbiol2021https://conductscience.org/library/papers/34778110PubMed
33720977Deletion of a Golgi protein in Trypanosoma cruzi reveals a critical role for Mn2+ in protein glycosylation needed for host cell invasion and intracellular replication.PLoS Pathog2021https://conductscience.org/library/papers/33720977PubMed
32793217The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence.Front Immunol2020https://conductscience.org/library/papers/32793217PubMed
31907197Induction of Effective Immunity against Trypanosoma cruzi.Infect Immun2020https://conductscience.org/library/papers/31907197PubMed
30949145Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host.Front Microbiol2019https://conductscience.org/library/papers/30949145PubMed
29513875Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.Mem Inst Oswaldo Cruz2018https://conductscience.org/library/papers/29513875PubMed
29434593Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host.Front Immunol2018https://conductscience.org/library/papers/29434593PubMed
28919885Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.Front Microbiol2017https://conductscience.org/library/papers/28919885PubMed
28473804The Complement System: A Prey of Trypanosoma cruzi.Front Microbiol2017https://conductscience.org/library/papers/28473804PubMed
28286708Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi.PeerJ2017https://conductscience.org/library/papers/28286708PubMed
27047464Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune Surveillance.Front Microbiol2016https://conductscience.org/library/papers/27047464PubMed
26834737Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection.Front Immunol2015https://conductscience.org/library/papers/26834737PubMed

See all 29 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C4B721PubTator's text mininghttps://conductscience.org/library/genes/721NCBI Gene
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9596703

GET https://conductscience.org/api/papers/v1/9596703/cited_by?page=2